FTEA
LLY icon

Forty-three Eighteen Advisors’s Eli Lilly LLY Stock Holding History

Forty-three Eighteen Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,334
Closed -$1.43M – 83
2025
Q4 		$1.43M Buy
+1,334
New +$1.28M 1.11% 33

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Forty-three Eighteen Advisors's LLY Position: Q1 2026 in Review

Forty-three Eighteen Advisors sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 1,334 shares — an estimated $1.43M sold.

Forty-three Eighteen Advisors first reported a position in LLY in Q4 2025 and held it in 1 quarter. The position peaked at $1.43M in Q4 2025. 4,379 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Forty-three Eighteen Advisors reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Forty-three Eighteen Advisors sold 1,334 Eli Lilly shares in Q1 2026, an estimated $1.43M.
  • Forty-three Eighteen Advisors first reported a position in Eli Lilly in Q4 2025 and held it in 1 quarter.
  • Forty-three Eighteen Advisors's Eli Lilly position peaked at $1.43M in Q4 2025.
  • 4,379 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Forty-three Eighteen Advisors's 13F filing for Q1 2026, filed 6 May 2026.